Table 1.
Baseline data of all patients with CDI.
| Total | TPS− | TPS+ | P | ||
|---|---|---|---|---|---|
| Subjects, n | 43 | 16 | 27 | — | |
|
| |||||
| Male/female, n | 23/20 | 12/4 | 11/16 | — | |
| Age at diagnosis, y | 7.47 ± 0.49 | 6.58 ± 0.67 | 8.01 ± 0.66 | 0.16 | |
| Interval, months | 22.29 ± 3.67 | 18.86 ± 5.99 | 24.32 ± 4.69 | 0.48 | |
|
| |||||
| Short stature, n | 17 (39.5%) | 5 (31.3%) | 12 (44.4%) | 0.39 | |
| Height SDS | –3.23 ± 0.24 | –3.48 ± 0.45 | –0.13 ± 0.29 | — | |
| BMI, kg/m2 | 16.12 ± 0.29 | 15.98 ± 0.42 | 16.20 ± 0.39 | 0.7 | |
| Urine 24 h, mL/kg | 202.7 ± 9.83 | 188.6 ± 12.99 | 211.0 ± 13.56 | 0.27 | |
|
| |||||
| APD | 23 (53.5%) | 6 (37.5%) | 17 (63%) | 0.11 | |
| IGHD | 15 | 6 (37.5%) | 9 (33.3%) | 0.36 | |
| MPHD | 8 | 0 | 8 (29.6%) | 0.02∗ | |
|
| |||||
| GHD +1 | 5 | 0 | 5 | — | |
| GHD +2∗ | 1 | 0 | 1 | — | |
| GHD +3∗ | 2 | 0 | 2 | — | |
|
| |||||
| Pituitary bright spot | Absent (100%) | Absent (100%) | Absent (100%) | — | |
|
| |||||
| AP | Normal | 26 (60.5%) | 12 (75%) | 14 (51.9%) | 0.13 |
| <Normal | 11 | 4 (25%) | 7 (25.9%) | 0.95 | |
| Not visible | 6 | 0 | 6 (22.2%) | 0.04∗ | |
∗ P < 0.05.
AP: anterior pituitary; APD: anterior pituitary deficiency; GHD: growth hormone deficiency; IGHD: isolate growth hormone deficiency.